Cargando…
Technologies for Detecting Falsified and Substandard Drugs in Low and Middle-Income Countries
Falsified and substandard drugs are a global health problem, particularly in low- and middle-income countries (LMIC) that have weak pharmacovigilance and drug regulatory systems. Poor quality medicines have important health consequences, including the potential for treatment failure, development of...
Autores principales: | Kovacs, Stephanie, Hawes, Stephen E., Maley, Stephen N., Mosites, Emily, Wong, Ling, Stergachis, Andy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3966738/ https://www.ncbi.nlm.nih.gov/pubmed/24671033 http://dx.doi.org/10.1371/journal.pone.0090601 |
Ejemplares similares
-
Future Information Technology Tools for Fighting Substandard and Falsified Medicines in Low- and Middle-Income Countries
por: Rasheed, Huma, et al.
Publicado: (2018) -
A cross-sectional analysis of falsified, counterfeit and substandard medicines in a low-middle income country
por: Khurelbat, Daariimaa, et al.
Publicado: (2020) -
Substandard and Falsified Medicines in Myanmar
por: Sakuda, Mirai, et al.
Publicado: (2020) -
Prevalence and Estimated Economic Burden of Substandard and Falsified Medicines in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis
por: Ozawa, Sachiko, et al.
Publicado: (2018) -
Surveillance for substandard and falsified medicines by local faith-based organizations in 13 low- and middle-income countries using the GPHF Minilab
por: Gnegel, Gesa, et al.
Publicado: (2022)